Gene expression profilers and conventional clinical markers to predict distant recurrences for premenopausal breast cancer patients after adjuvant chemotherapy
- 30 November 2006
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (16), 2729-2737
- https://doi.org/10.1016/j.ejca.2006.06.031
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Gene expression profiles relate to SS18/SSX fusion type in synovial sarcomaInternational Journal of Cancer, 2005
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancerThe Lancet, 2005
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- “Good Old” clinical markers have similar power in breast cancer prognosis as microarray gene expression profilersEuropean Journal Of Cancer, 2004
- ACID: a database for microarray clone informationBioinformatics, 2004
- Breast cancer classification and prognosis based on gene expression profiles from a population-based studyProceedings of the National Academy of Sciences, 2003
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991